Azevan Pharmaceuticals
PrivateLast Round
Grant
Mar 1, 2026
Total Funding Raised
$11.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Azevan Pharmaceuticals is a biotechnology company that develops novel small-molecule therapeutics to treat stress-related central nervous system disorders and neurodegenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azevan Pharmaceuticals Comparables
Compare Azevan Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuphoria Therapeutics Inc. | 77% | |
| MapLight Therapeutics | 73% | |
| Nobilis Therapeutics | 73% |
Azevan Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2026 | ||||
| Series C | Oct 1, 2013 |
Azevan Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Scientific Health Development | Series C |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Ascent Biomedical Ventures | Series C |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Received grant from the United States Department of Defense.
- Jan 31, 2026
Monthly visitors grew 92% MoM.
Azevan Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Azevan Pharmaceuticals's valuation, stock price, and market status.
Is Azevan Pharmaceuticals a public or private company?
Azevan Pharmaceuticals is a private company.
What is the current stock price of Azevan Pharmaceuticals?
Azevan Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Azevan Pharmaceuticals worth (valuation)?
Valuation information for Azevan Pharmaceuticals is not publicly available.
Can I buy Azevan Pharmaceuticals stock?
Azevan Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Azevan Pharmaceuticals's last funding round?
Funding round information for Azevan Pharmaceuticals is not publicly available.
Who are the main investors in Azevan Pharmaceuticals?
Investor information for Azevan Pharmaceuticals is not publicly disclosed.
Will Azevan Pharmaceuticals IPO soon?
No public IPO plans have been announced for Azevan Pharmaceuticals.
How can I track Azevan Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Azevan Pharmaceuticals's secondary market activity and sign up for updates.